Comprehensive medication guide to Fosfomycin including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$10–$50 copay depending on plan; fosfomycin may be placed on Tier 2 or Tier 3 of many formularies. Some commercial plans and Medicare Part D require prior authorization before covering it.
Estimated Cash Pricing
$85–$110 retail for brand Monurol; generic fosfomycin tromethamine typically $85–95 at retail. With GoodRx or SingleCare coupons, generic can be as low as $33 for a single 3g packet.
Medfinder Findability Score
68/100
Summarize with AI
On this page
Fosfomycin (brand name Monurol) is a broad-spectrum antibiotic used to treat urinary tract infections (UTIs). It belongs to the phosphonic acid antibiotic class — a unique category structurally unrelated to all other antibiotic classes, including penicillins, cephalosporins, fluoroquinolones, and sulfonamides. This structural uniqueness means bacteria resistant to those common antibiotics often remain susceptible to fosfomycin.
The FDA-approved oral formulation (fosfomycin tromethamine) comes as granules in a single-dose packet that you dissolve in water and drink. One 3-gram dose treats most uncomplicated bladder infections in women. Fosfomycin was originally FDA-approved in 1996 and has been recommended as a first-line UTI treatment by the Infectious Diseases Society of America (IDSA) since 2011.
In November 2025, the FDA also approved an intravenous formulation called Contepo (by Meitheal Pharmaceuticals) for complicated UTIs in hospitalized adults — expanding fosfomycin's clinical reach into hospital settings for serious infections caused by resistant organisms.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Fosfomycin works by permanently inactivating a bacterial enzyme called MurA (UDP-N-acetylglucosamine enolpyruvyl transferase). MurA catalyzes the very first step in the synthesis of peptidoglycan — the material that forms the bacterial cell wall. Without a functional cell wall, bacteria cannot survive internal osmotic pressure and die.
This mechanism is unique: no other currently marketed antibiotic inhibits MurA. As a result, there is no cross-resistance between fosfomycin and other antibiotic classes. Bacteria that have evolved beta-lactamases (to destroy penicillins), efflux pumps (to expel fluoroquinolones), or altered targets (to evade TMP-SMX) cannot use those same mechanisms to resist fosfomycin.
After oral administration, fosfomycin is absorbed and then excreted almost entirely unchanged into the urine, achieving very high urinary concentrations (often exceeding 1,000 mcg/mL) that remain bactericidal for 24-48 hours from a single dose — enough to treat an uncomplicated bladder infection with one administration.
3 g — granules for oral solution (sachet)
Single-dose packet dissolved in water — standard FDA-approved dose for uncomplicated UTIs in women
6 g — IV solution (Contepo)
Intravenous formulation for hospital use; 6g every 8 hours for 7 days for complicated UTIs
Fosfomycin is not currently on the FDA's national drug shortage list as of 2026. At the manufacturer level, supply is considered adequate. However, individual retail pharmacies frequently maintain only small quantities in stock — often 2-5 packets — because fosfomycin is a single-dose antibiotic with slower per-unit inventory turnover compared to multi-day antibiotic regimens.
This means patients can encounter "out of stock" situations at their first-choice pharmacy, even though the drug is nationally available. A few recent prescriptions can deplete a smaller pharmacy's entire supply until their next distributor delivery. Calling multiple pharmacies or using a pharmacy-finding service significantly increases the likelihood of finding it same-day.
medfinder contacts pharmacies near you to check fosfomycin availability on your behalf, so you don't have to spend your afternoon on hold. Enter your medication and location and receive pharmacy results via text.
Fosfomycin is not a controlled substance and is not DEA-scheduled. Any licensed healthcare provider with prescriptive authority can prescribe it without special registration or restrictions. This makes it widely accessible through multiple care settings.
Primary care physicians (PCPs): Family medicine and internal medicine physicians routinely prescribe fosfomycin for uncomplicated UTIs
OB/GYN physicians: Commonly prescribe fosfomycin for UTIs in women, including during pregnancy
Urologists: Specialists for urinary tract conditions, including UTIs, bladder infections, and prostatitis
Infectious disease specialists: For complex or drug-resistant UTIs where fosfomycin's activity against MDR/ESBL organisms is being utilized
Nurse practitioners (NPs) and physician assistants (PAs): NPs with full prescriptive authority (available in most states) and PAs can prescribe fosfomycin without special restrictions
Urgent care providers: Walk-in urgent care clinics can diagnose UTIs and prescribe fosfomycin
Fosfomycin can be prescribed via telehealth for uncomplicated UTIs without an in-person visit. Multiple telehealth platforms offer same-day UTI consultations in 2026, making it one of the most accessible UTI antibiotics to obtain via remote care.
No. Fosfomycin is not a controlled substance and is not scheduled by the Drug Enforcement Administration (DEA). It does not have abuse potential or dependency concerns, and it does not require a DEA registration number to prescribe.
This means any licensed healthcare provider with prescriptive authority can prescribe fosfomycin — including primary care physicians, OB/GYNs, nurse practitioners, physician assistants, and telehealth providers. There are no special regulations around refills, prescription quantity, or prescriber type for this medication. It can be prescribed at a standard office visit, urgent care, or via telehealth.
Fosfomycin is generally well-tolerated. Most patients experience few or no side effects from the single oral dose. Common side effects reported in clinical trials include:
Diarrhea (most common — usually mild)
Nausea
Headache
Vaginitis
Back pain
Rhinitis (runny nose)
Abdominal pain / indigestion
C. difficile-associated diarrhea (CDAD): Seek immediate care if you develop severe, watery, or bloody diarrhea with fever or stomach cramps — can occur up to 2 months after antibiotics
Anaphylaxis / anaphylactic shock: Rare but serious allergic reaction — seek emergency care immediately if you experience hives, swelling, or difficulty breathing
Toxic megacolon: Extremely rare complication associated with severe C. diff infection
Know what you need? Skip the search.
Nitrofurantoin (Macrobid)
First-line UTI antibiotic; 100 mg twice daily for 5-7 days. Widely stocked, low resistance rates (~1-2% for E. coli), safe in pregnancy. Best alternative when fosfomycin is unavailable.
Trimethoprim-Sulfamethoxazole (Bactrim)
First-line UTI option; 1 DS tablet twice daily for 3 days. Very inexpensive ($4-8 generic). Not for sulfa allergy; check local resistance rates (use if <20% in your area).
Cephalexin (Keflex)
Second-line UTI antibiotic; 500 mg twice daily for 7 days. Broader spectrum than fosfomycin; used when first-line agents are contraindicated or unavailable.
Ciprofloxacin
Reserved for complicated UTIs or culture-directed therapy. Not recommended as first-line for uncomplicated cystitis due to resistance concerns and FDA safety warnings.
Prefer Fosfomycin? We can find it.
Metoclopramide (Reglan)
moderateReduces fosfomycin absorption by increasing GI motility, lowering urinary concentrations and potentially reducing efficacy. Separate dosing or use alternative antibiotic.
Live bacterial vaccines (BCG, oral typhoid, oral cholera)
majorFosfomycin may inactivate live bacterial vaccine strains. Complete antibiotic therapy before administering live vaccines.
Oral contraceptives / estrogens
minorFosfomycin may alter intestinal flora affecting oral hormone activation. Low clinical significance for single-dose treatment. Backup contraception may be considered as precaution.
Digoxin (oral)
moderateFosfomycin may slightly increase digoxin levels via altered intestinal flora. Clinical significance low for single-dose treatment; monitor patients on digoxin.
Fosfomycin (Monurol) is a highly effective, uniquely convenient antibiotic for urinary tract infections. Its single-dose regimen, unique mechanism of action, activity against drug-resistant bacteria, and pregnancy compatibility make it a standout option among UTI antibiotics. Its main practical limitations are intermittent pharmacy-level stock gaps and a higher retail cost compared to older UTI antibiotics.
If your pharmacy is out of stock, don't assume it's unavailable everywhere — check multiple pharmacies or use a pharmacy-finding service. If cost is a barrier, GoodRx coupons can reduce the generic price to as low as $33. If your insurance requires prior authorization, work with your prescriber to document the clinical justification.
If you're having trouble locating fosfomycin at a pharmacy near you, medfinder can help. It's a service that contacts pharmacies in your area to find which ones have your medication in stock, so you can get treatment without spending your afternoon on the phone.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards